Measles epidemiology and outbreak investigation using IgM test in Laos
Related Experiment Video
Updated: Oct 3, 2026

Developing a Salivary Antibody Multiplex Immunoassay to Measure Human Exposure to Environmental Pathogens
Published on: September 12, 2016
C Kuroiwa1, P Vongphrachanh, P Xayyavong
1Bureau of International Cooperation, International Medical Center of Japan, and Japan International Cooperation Agency in Lao PDR, Tokyo.
Abstract:
Following the Pan American Health Organization (PAHO) recommendation on measles elimination, the Western Pacific Region of WHO (WPR) is emphasizing accelerated measles control programme especially since the achievement of polio eradication in WPR in 2000. This includes upgraded surveillance and mass measles vaccination campaign for children aged 9 months to 4 years. However, there are limited scientific evidences supporting the feasibility of this programme in Laos. To examine measles elimination feasibility in the country, we conducted measles outbreak investigation using immunoglobulin M (IgM). From March 1999 to March 2000, we conducted 7 outbreak investigations. At the outbreak sites, we examined clinical manifestations of cases and collected individual data. About five blood samples were drawn from each outbreak, and IgM antibodies to measles were tested. Of 7 investigated outbreaks, 5 were confirmed as measles, one was chickenpox, and one occurred in the inaccessible area due to flooding. In a village of high land Lao, blood drawn was refused. Of 185 cases, 64 (34.6%) cases were immunized, and 110 (59.5%) were unimunized. The estimated vaccine efficacy is 67.9%. The number of measles cases among school-aged children was 74 (40.0%), which represented 2.5% of the total population in investigated villages. Our findings showed various difficulties of the surveillance and the limited outcomes of mass measles vaccination campaign under the accelerated measles control programme by WPR. Efforts to improve cold chain as well as increasing routine immunization coverage must be the priority of measles control.
Insights
Measles elimination efforts in Laos faced challenges, with limited vaccine efficacy (67.9%) and surveillance difficulties. Improving cold chain and routine immunization coverage are crucial for measles control.
Area of Science:
- Public Health
- Epidemiology
- Vaccinology
Background:
- The Western Pacific Region of WHO (WPR) is accelerating measles control programs following Pan American Health Organization (PAHO) recommendations for measles elimination.
- Polio eradication in WPR in 2000 prompted emphasis on measles control, including enhanced surveillance and mass vaccination campaigns for children aged 9 months to 4 years.
Purpose of the Study:
- To investigate measles outbreak feasibility in Laos using immunoglobulin M (IgM) testing.
- To assess the effectiveness of accelerated measles control programs in Laos.
Main Methods:
- Conducted 7 measles outbreak investigations from March 1999 to March 2000.
- Examined clinical manifestations and collected individual data at outbreak sites.
- Tested blood samples for measles IgM antibodies, with 5 samples per outbreak.
Main Results:
- Five of 7 investigated outbreaks were confirmed as measles; one was chickenpox, and one was inaccessible.
- Of 185 cases, 64 (34.6%) were immunized and 110 (59.5%) were unimmunized, yielding an estimated vaccine efficacy of 67.9%.
- Measles cases among school-aged children represented 40.0% of cases and 2.5% of the total village population.
Conclusions:
- Surveillance for measles in Laos presented significant difficulties.
- The outcomes of mass measles vaccination campaigns were limited, highlighting challenges in the WPR's accelerated measles control program.
- Prioritizing cold chain improvements and increasing routine immunization coverage is essential for effective measles control in Laos.
More Related Videos
08:42Immunohistochemistry Test for the Lyssavirus Antigen Detection from Formalin-Fixed Tissues
Published on: October 26, 2021
11:28Analysis of Iophenoxic Acid Analogues in Small Indian Mongoose (Herpestes Auropunctatus) Sera for Use as an Oral Rabies Vaccination Biological Marker
Published on: May 31, 2019
Related Concept Videos
Investigation of Disease Outbreaks
Steps in Outbreak Investigation
Infectious Diseases and Their Occurrence